531-540 of 665 results
No relief in PBS price changes for originators seeking injunctions
Patentees may face heightened risks when changes to the Pharmaceutical Benefits Scheme (PBS) take effect later this year. Special Counsel Ric Morgan and Associate Claire Gregg explain. ...
What you need to know about mandatory data breach notification
In response to the rising number of cyberattacks, new legislation has been introduced that proposes a mandatory notification regime that will take effect from February next year. ...
Nurofen maker in need of fast pain relief
Paracetamol manufacturer Hence Reckitt Benckiser has discovered that inaccurate and unbalanced comparative claims that don't reflect the overall picture can cause big headaches, even where those claims have some support. ...
Will Ed Sheeran be facing copyright lawsuits for The Rest of Our (or his) Life?
It's a new year and, in what is seemingly becoming an annual tradition, a new copyright infringement lawsuit has been filed against pop superstar Ed Sheeran. ...
Unexpected risks of the IoT revolution: Cyber security in medical devices
In late August 2017 the US Food and Drug Administration recalled 465000 Abbott Laboratories pacemakers due to cyber security vulnerabilities Although this was the first time that the FDA had recalled a medical device because of cyber concerns they have been alive to the significant risk that a cyber ...
NSW to go it alone on a tort of privacy?
A New South Wales legislative committee has released a report following an inquiry into remedies for serious invasions of privacy in New South Wales In an unexpected and controversial move the report recommends that the NSW Government take the lead by introducing a statutory cause of action for ...
Special Report: Understanding the opportunities and navigating the legal frameworks of distributed ledger technology and blockchain
Authored by a multidisciplinary team from Allens Blockchain Reaction is designed to assist business stakeholders decision makers and in-house counsel across a variety of sectors to understand the technology and how it is being used as well as navigate the regulatory and legal opportunities and ...
What's in a (biosimilar) name?
Because biosimilars and their reference biologic medicine are not identical whether compared to each other or even between biosimilars it is important to know which product has been used ...
Four key principles from Sigma v Wyeth
Justice Jagot's mammoth judgment in Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth sets down important principles relating to claims for damages under the usual undertaking as to damages, where an interlocutory injunction has been wrongly granted. ...
Victory for software innovators as APO gets ROKTed
Australian start-up ROKT has had a major win in the fight for software-related inventions. Senior Associate and Patent Attorney Pasquale Aliberti considers the ramifications. ...